124 related articles for article (PubMed ID: 8365434)
1. Reappraisal of the biological role of epidermal growth factor receptor in transitional cell carcinoma.
Chow NH; Tzai TS; Lin SN; Chan SH; Tang MJ
Eur Urol; 1993; 24(1):140-3. PubMed ID: 8365434
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis.
Nguyen PL; Swanson PE; Jaszcz W; Aeppli DM; Zhang G; Singleton TP; Ward S; Dykoski D; Harvey J; Niehans GA
Am J Clin Pathol; 1994 Feb; 101(2):166-76. PubMed ID: 7906919
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric evaluation of transferrin receptor in transitional cell carcinoma.
Rahman SA; Yokoyama M; Nishio S; Takeuchi M
Urol Res; 1997; 25(5):325-9. PubMed ID: 9373912
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric bromodeoxyuridine/deoxyribonucleic acid bivariate analysis for predicting tumor invasiveness of upper tract urothelial cancer.
Miyakawa A; Tachibana M; Nakashima J; Deguchi N; Baba S; Tazaki H
J Urol; 1994 Jul; 152(1):76-80. PubMed ID: 8201694
[TBL] [Abstract][Full Text] [Related]
6. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
Lipponen P; Eskelinen M
Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
[TBL] [Abstract][Full Text] [Related]
7. Transitional cell carcinoma of the renal pelvis and ureter in Taiwan. DNA analysis by flow cytometry.
Chiang PH; Huang MS; Tsai CJ; Tsai EM; Huang CH; Chiang CP
Cancer; 1993 Jun; 71(12):3988-92. PubMed ID: 8508364
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder.
Berner A; Jacobsen AB; Fosså SD; Nesland JM
Histopathology; 1993 Apr; 22(4):327-33. PubMed ID: 8099896
[TBL] [Abstract][Full Text] [Related]
9. Epithelial differentiation antigens and epidermal growth factor receptors in transitional cell bladder carcinoma: correlation with prognosis.
Nakopoulou L; Zervas A; Constantinides C; Deliveliotis C; Stefanaki K; Dimopoulos C
Urol Int; 1995; 54(4):191-7. PubMed ID: 7541921
[TBL] [Abstract][Full Text] [Related]
10. [Expression of transferrin receptor on transitional cell cancer].
Tomita Y; Nishiyama T; Sato S; Fujiwara M
Hinyokika Kiyo; 1991 Jan; 37(1):11-6. PubMed ID: 2011963
[TBL] [Abstract][Full Text] [Related]
11. [Transitional bladder carcinoma TaG1: role of the EGFr tyrosin kinase activation in the cellular proliferation].
Blasco M; Losada J; Fernández Val JF; Sarría R
Med Clin (Barc); 2003 Nov; 121(17):641-4. PubMed ID: 14642223
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of DNA ploidy pattern in transitional cell cancer of the renal pelvis and ureter: continuing follow-up.
Corrado F; Mannini D; Ferri C; Corrado G; Bertoni F; Bacchini P; Lieber MM; Song JM
Eur Urol; 1992; 21 Suppl 1():48-50. PubMed ID: 1425836
[TBL] [Abstract][Full Text] [Related]
13. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients.
Gorgoulis VG; Barbatis C; Poulias I; Karameris AM
Mod Pathol; 1995 Sep; 8(7):758-64. PubMed ID: 8539234
[TBL] [Abstract][Full Text] [Related]
14. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
Cuatrecasas M; Catasus L; Palacios J; Prat J
Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
[TBL] [Abstract][Full Text] [Related]
15. [Association of uPA and uPAR expression with invasive behaviors of urinary transitional cell carcinoma].
Li YJ; Zheng BZ; Zhou ZL
Ai Zheng; 2004 Jun; 23(6):704-6. PubMed ID: 15191676
[TBL] [Abstract][Full Text] [Related]
16. Near-diploid transitional cell carcinoma: a preliminary report.
Chow NH; Tzai TS; Lin SN; Su WC; Cheng HL
Int Urol Nephrol; 1994; 26(4):423-30. PubMed ID: 8002215
[TBL] [Abstract][Full Text] [Related]
17. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
[TBL] [Abstract][Full Text] [Related]
18. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
19. Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumour recurrence at the urinary bladder.
Imai T; Kimura M; Takeda M; Tomita Y
Br J Cancer; 1995 Jan; 71(1):69-72. PubMed ID: 7819052
[TBL] [Abstract][Full Text] [Related]
20. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
al-Abadi H; Nagel R
J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
